Introducing CLE-400; Topical Alpha-2- Adrenergic Agonist as a First-in- Class Treatment for Localized Chronic Pruritus
Time: 1:30 pm
day: Conference Day Two
Details:
- Exploring activation of α2 adrenergic receptors on skin nociceptors in attenuating neural itch signaling
- Detailing the effects of CLE-400 in preclinical pharmacological models
- Presenting Notalgia Ptaresthetica as the first indication for CLE 400’s clinical development
